Bone diseases: Sclerostin neutralization--a viable pathway for OPPG?
- PMID: 24296680
- DOI: 10.1038/nrrheum.2013.189
Bone diseases: Sclerostin neutralization--a viable pathway for OPPG?
Comment on
-
Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome.Sci Transl Med. 2013 Nov 13;5(211):211ra158. doi: 10.1126/scitranslmed.3006627. Sci Transl Med. 2013. PMID: 24225945 Free PMC article.
References
-
- Sci Transl Med. 2013 Nov 13;5(211):211ra158 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical